1. News
  2. Sector

  3. Pharma & Healthcare

Lupin in, Tata Power out from Sensex Index

India Infoline News Service | Mumbai | May 22, 2015 18:32 IST

BSE has announced reconstitution of benchmark Sensex Index. The exchange has decided to add Lupin to Sensex Index and to remove Tata Power from the Index, as per media reports, and the changes will take effect from June 22, 2015.

FIIs can Invest up to 35% under PIC In Ipca Laboratories

India Infoline News Service | Mumbai | May 22, 2015 17:30 IST

The Reserve Bank further notified that FIIs/RFPIs can now invest up to 35 per cent of the paid up capital of M/s Ipca Laboratories Ltd. under the Portfolio Investment Scheme (PIS).

Wockhardt stock surges on QIDP designation for WCK 4873 from U.S. FDA

India Infoline News Service | Mumbai | May 22, 2015 16:43 IST

This is the third product from Wockhardt to receive this coveted status after WCK 771 and WCK 2349 last year and provides a strong boost to its drug development program.

Suven Life closes in green on receiving product patents

India Infoline News Service | Mumbai | May 22, 2015 16:16 IST

The granted claims of the patents include the class of selective alpha-4-beta-2 compounds discovered by Suven and are being developed as therapeutic agents for major depressive disorder

Fortis Medics successfully treat over 5000 quake victims in Nepal

India Infoline News Service | Mumbai | May 22, 2015 15:50 IST

Team Fortis SEWA has been working with the Nepalese Army to mount relief operations where they have been most needed.

Strides Arcolab Q4 net profit at Rs.69.7 crore; Operating Margin at 15.8%

India Infoline News Service | Mumbai | May 22, 2015 13:23 IST

The company's Total Income stood at Rs. 270 crore Vs Rs. 256.7 crore (YoY). EBITDA increased to Rs. 43 crore in Q4 FY15 compared to Rs.30 crore in Q4 FY14.

Pharmaceuticals Newsletter - May 18 to 22, 2015

India Infoline News Service | Mumbai | May 22, 2015 12:15 IST

Cipla is recalling 140,625 vials of generic levalbuterol inhalers in US market used for relieving shortness of breath and coughing caused by asthma and chronic obstructive pulmonary disease, according to reports.

Suven Life gets one product patent each in Mexico & Singapore

India Infoline News Service | Mumbai | May 22, 2015 10:18 IST

The granted claims of the patents include the class of selective alpha-4-beta-2 compounds discovered by Suven and are being developed as therapeutic agents for major depressive disorder.

Wockhardt jumps after getting nod from USFDA

India Infoline News Service | Mumbai | May 22, 2015 09:51 IST

The company has announced USFDA has granted WCK 4873, a product from their New Drug Discovery program, QIDP status.

Natco Pharma board to consider raising FII investment limit

India Infoline News Service | Mumbai | May 22, 2015 08:50 IST

Natco Pharma Ltd has announced that a meeting of the Board of Directors of the Company will be held on May 22, 2015.

Cipla recalls over 1.4 lakh vials of asthma drug in US market: Reports

India Infoline News Service | Mumbai | May 21, 2015 18:52 IST

A report said that the company vials were manufactured by Cipla at its Pithampur manufacturing facility, near Indore,

P&G Manoj Kumar takes over as MD of GSK Consumer Healthcare India Sub-Continent

India Infoline News Service | Mumbai | May 21, 2015 17:56 IST

GlaxoSmithKline Consumer Healthcare Limited also announced the appointment of Vivek Anand as Director Finance and Chief Financial Officer.

CVS Health to buy Omnicare

India Infoline News Service | Mumbai | May 21, 2015 17:36 IST

With the acquisition of Omnicare, CVS Health will significantly expand its ability to dispense prescriptions in assisted living and long term care facilities, serving the senior patient population. CVS Health will also expand its presence in the rapidly growing specialty pharmacy business

Aarti Drugs plunges 7% as Q4 disappoints

India Infoline News Service | Mumbai | May 21, 2015 16:23 IST

The company reported 14 per cent drop in standalone Q4 net profit at Rs. 18.66 crore in Q4 March 2015, as compared to net profit of Rs. 21.95 crore in Q4 March 2014.

Claris Lifesciences zooms 10%...may evaluate inorganic and strategic opportunities

India Infoline News Service | Mumbai | May 21, 2015 16:12 IST

The Company has clalrified that it continues to explore and evaluate inorganic and strategic opportunities in various forms from time to time; however nothing definitive in this regard has happened.

Strides Arcolab rallies 9% on acquiring generic drugs business

India Infoline News Service | Mumbai | May 21, 2015 16:06 IST

The company announced that it has signed definitive agreement to acquire a generic pharmaceutical business in Australia and related assets from Aspen.

Wockhardt receives QIDP designation for WCK 4873 from U.S. FDA

India Infoline News Service | Mumbai | May 21, 2015 15:27 IST

This is the third product from Wockhardt to receive this coveted status.

TTK Healthcare Q4 net Profit at Rs.4.5 Crore

India Infoline News Service | Mumbai | May 21, 2015 14:43 IST

Total Income for the quarter was at Rs.111.9 Crore.

Strides Arcolab to buy Aspen's generic pharma

India Infoline News Service | Mumbai | May 21, 2015 12:20 IST

The business will operate under the Arrow Pharmaceuticals brand, will sell approximately 140 generic prescription drugs and an extensive range of non-prescription pharmacy products.

Back to Top

Recent Reports

Lower product prices put pressure on earnings

India Infoline Research Team / 14:59, May 20, 2015

GPIL reported 13.5% yoy decline in operating profit as the impact of higher volumes was offset by lower product prices

News